Semisynthesis and Biological Evaluation of Platencin Thioether Derivatives: Dual FabF and FabH Inhibitors against MRSA-Reference-Cited by-同舟云学术

Semisynthesis and Biological Evaluation of Platencin Thioether Derivatives: Dual FabF and FabH Inhibitors against MRSA

Published:2021-02-15 Issue:3 Volume:12 Page:433-442
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Li Yuling¹,Weng Xiang¹,Deng Youchao¹,Pan Jian¹,Zhu Saibin¹,Wen Zhongqing¹,Yuan Yanqiu²^ORCID,Li Shaowen³,Shen Ben⁴^ORCID,Duan Yanwen¹⁵⁶,Huang Yong¹⁶^ORCID

Affiliation:

1. Xiangya International Academy of Translational Medicine at Central South University, Changsha, Hunan 410013, China

2. School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China

3. State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei 430070, China

4. Departments of Chemistry and Molecular Medicine and Natural Product Discovery Center at Scripps Research, Scripps Research, Jupiter, Florida 33458, United States

5. Hunan Engineering Research Center of Combinatorial Biosynthesis and Natural Product Drug Discovery, Changsha, Hunan 410011, China

6. National Engineering Research Center of Combinatorial Biosynthesis for Drug Discovery, Changsha, Hunan 410011, China

Funder

State Administration of Foreign Experts Affairs

Ministry of Education of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.0c00653

Reference47 articles.

1. Combination approaches to combat multidrug-resistant bacteria

2. New Drugs at FDA: CDER’s New Molecular Entities and New Therapeutic Biological Products. https://www.fda.gov/drugs/development-approval-process-drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products (accessed 2020-02-25).

3. Multi-targeting by monotherapeutic antibacterials

4. Bacterial fatty acid metabolism in modern antibiotic discovery

5. Bacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug Discovery

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR;Journal of Antimicrobial Chemotherapy;2024-02-27

2. Phenotypic screening of covalent compound libraries identifies chloromethyl ketone antibiotics and MiaA as a new target;2024-01-23

3. Semisynthesis of antibiotics;Semisynthesis of Bioactive Compounds and their Biological Activities;2024

4. Flourishing Antibacterial Strategies for Osteomyelitis Therapy;Advanced Science;2023-01-30

5. Design, Synthesis and Molecular Docking of 1,3,4‐Oxadiazole‐2(3 H )‐thione Derivatives Containing 1,4‐Benzodioxane Skeleton as Potential FabH Inhibitors;Chemistry & Biodiversity;2023-01-12